Oxaloacetate Treatment For Mental And Physical Fatigue In Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Long-COVID fatigue patients: a non-randomized controlled clinical trial.

Graphical Abstract Keywords: Oxaloacetate, ME/CFS, Post viral fatigue, Chronic fatigue syndrome, ME/CFS treatment, ME/CFS clinical, Anhydrous enol oxaloacetate, Long COVID, COVID fatigue Key points Question: Can normalization of metabolism with oxaloacetate help reduce fatigue in ME/CFS and Long COVID? Findings: Patients with ME/CFS and Long-COVID treated with oral Anhydrous Enol-Oxaloacetate capsules achieved highly significant reductions in physical and mental fatigue within 6 weeks.

also in 132,142 other papers